Update on COVID-19 in Transplantation: from Travel to Treatment
On May 24, 2022, the Massachusetts General Hospital Transplant Center held a virtual, fireside chat to share the latest updates on COVID-19 and transplantation.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Corrigan Minehan Heart Center
Contact Us
Corrigan Minehan Heart Center
55 Fruit Street
Boston,
MA
02114
Phone: 866-644-8910
Email: mghheartcenter@partners.org
Treatment for hypertension at Massachusetts General Hospital is a specialized medical service for patients who have elevated blood pressure. Specialists evaluate newly diagnosed patients who have not yet been treated, patients who have already been diagnosed but have trouble controlling their high blood pressure, and patients who have not tolerated traditional therapy. These patients may refer themselves to the service or be referred by their primary care physician or specialist.
The treatment regimen might include anti-hypertensive drug therapy and lifestyle modifications such as exercise, weight loss, diet modification, smoking cessation and stress reduction. Many patients also have other conditions such as high cholesterol, diabetes, cardiac arrhythmias, coronary artery disease, angina pectoris or other disorders that might affect the treatment regimen. Specialists are able to treat these patients with individualized therapies that control blood pressure elevation without side effects or disrupting their lifestyles.
Our services also maintain a close relationship with the Benson-Henry Institute for Mind-Body Medicine and use their program for stress management and relaxation response services that facilitate blood pressure control.
The Corrigan Minehan Heart Center, in collaboration with the Nephrology and Endocrinology divisions, offers a Resistant Hypertension Program that specializes in the evaluation, diagnosis and management of patients with resistant or difficult-to-treat hypertension. The American Heart Association defines resistant hypertension as blood pressure that remains above goal despite the use of three antihypertensive agents in full dose, one of which is a diuretic. Patients with resistant hypertension are at high risk for cardiovascular, brain and kidney complications. The Mass General Resistant Hypertension Program provides a multidisciplinary approach to care, including pharmacologic and non-pharmacologic approaches to blood pressure control as well as interventional options. Services offered include:
Hypertension specialists are involved in numerous clinical research protocols for patients with high blood pressure, as well as high cholesterol, diabetes, coronary artery disease, myocardial infarction (heart attack) and atrial fibrillation. Patients benefit from our involvement in innovative research because they have access to the latest therapies and treatment information.
We are currently seeking participants for the following clinical trials:
Mass General is dedicated to ensuring that people understand their health care choices and have the necessary information to make decisions affecting their health and wellbeing. The related support and wellness information listed below can play a role in treatment options.
Topics include disease prevention, symptom management, medications and managing stress.
Learn how to modify your diet to keep a healthy heart.
Explore relaxation techniques including yoga, tai chi, visualization and meditation.
Our physicians welcome second opinion appointments to review cases and proposed lines of treatment.
Our physicians welcome second opinion appointments to review cases and proposed lines of treatment.
On May 24, 2022, the Massachusetts General Hospital Transplant Center held a virtual, fireside chat to share the latest updates on COVID-19 and transplantation.
Women who had experienced infertility had a 16% increased risk of heart failure compared with women who did not have an infertility history.
Advanced consumer technology has produced small electrocardiogram devices that could be efficiently deployed in point-of-care screening for atrial fibrillation, though the proportion of cases detected among all patients 65 and older is small.
Mutations in genes that direct the production of fibrillar collagens, essential components of blood vessel walls, appear to predispose individuals to SCAD.
Heart disease is the leading cause of death in men and women alike. In this presentation, Dr. Emily Lau reviews the epidemiology of heart disease in women, differences in heart disease between women and men, and special considerations for promoting female heart health.
“Thank you for your service” is a phrase shared with U.S. service members. But Mass General’s Shannon Stuart, RN, a commissioned officer with the Air National Guard, says she is the one who feels the need to share her appreciation.
Call us to learn more, or request an appointment online.